Application 761092
- Type
- BLA
- Sponsor
- LEADIANT BIOSCI INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | REVCOVI | ELAPEGADEMASE-LVLR | INJECTABLE;INJECTION | 1.6MG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 10122-502 | Revcovi | elapegademase-lvlr | Chiesi USA, Inc. | BLA | Current |
| 10122-502 | Revcovi | elapegademase-lvlr | Chiesi USA, Inc. | BLA | Current |
| 10122-502 | Revcovi | elapegademase-lvlr | Chiesi USA, Inc. | BLA | Current |
| 57665-002 | Revcovi | elapegademase-lvlr | Leadiant Biosciences, Inc. | BLA | Current |
| 57665-002 | Revcovi | elapegademase-lvlr | Leadiant Biosciences, Inc. | BLA | Current |
| 57665-002 | Revcovi | elapegademase-lvlr | Leadiant Biosciences, Inc. | BLA | Current |
| 57665-002 | Revcovi | elapegademase-lvlr | Leadiant Biosciences, Inc. | BLA | Current |
| 57665-002 | Revcovi | elapegademase-lvlr | Leadiant Biosciences, Inc. | BLA | Current |
| 57665-002 | Revcovi | elapegademase-lvlr | Leadiant Biosciences, Inc. | BLA | Current |
| 57665-002 | Revcovi | elapegademase-lvlr | Leadiant Biosciences, Inc. | BLA | Current |
| 57665-002 | Revcovi | elapegademase-lvlr | Leadiant Biosciences, Inc. | BLA | Current |
| 57665-002 | Revcovi | elapegademase-lvlr | Leadiant Biosciences, Inc. | BLA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 65529 | SUPPL | 2020-12-08 |
| 65514 | SUPPL | 2020-12-07 |
| 56322 | ORIG | 2018-11-07 |
| 55936 | ORIG | 2018-10-15 |
| 55849 | ORIG | 2018-10-05 |